Procter & Gamble Hygiene and Health Care Limited reported a strong financial performance for the quarter ended December 31, 2024 (Q3 FY25). The company achieved notable growth in both revenue and net profit, driven by effective cost control and solid operational execution.

The revenue from operations for Q3 FY25 stood at Rs 1,247.63 crore, registering a 9.68% increase compared to Rs 1,133.43 crore in Q3 FY24. The company’s consistent demand for hygiene and health care products contributed to this growth.

Net profit for the quarter increased to Rs 268.59 crore, reflecting a growth of 17.33% compared to Rs 228.90 crore in Q3 FY24. The profit growth was bolstered by improved operational efficiencies and a reduction in advertising and promotional expenses.

Total expenses for the quarter amounted to Rs 983.21 crore, compared to Rs 840.50 crore in the same period last year. The cost of raw and packing materials consumed was Rs 391.82 crore, while purchases of stock-in-trade amounted to Rs 462.86 crore. Employee benefit expenses stood at Rs 126.68 crore, reflecting the company’s efforts to maintain workforce efficiency.

Profit before tax increased to Rs 368.43 crore, up from Rs 308.51 crore in the previous year, showcasing the company’s improved profit margins. The company’s tax expense for the quarter was Rs 89.74 crore, resulting in a net profit of Rs 268.59 crore.

Key Highlights:

  • Revenue from operations: Rs 1,247.63 crore, up 9.68% YoY
  • Net profit: Rs 268.59 crore, up 17.33% YoY
  • Profit before tax: Rs 368.43 crore, reflecting strong operational gains

Procter & Gamble’s continued focus on cost management, operational excellence, and sustained demand for hygiene products has contributed to its robust quarterly performance.

Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.

TOPICS: Procter & Gamble